重视高危因素,规范管理、合理诊治妊娠期血栓栓塞性疾病——《2018 ACOG实践简报:妊娠期血栓栓塞症的临床管理指南》解读

Pay Attention to High-risk Factors,Standardize Management,and Reasonably Diagnose and Treat Thromboembolic Diseases during Pregnancy——Interpretation of ACOG Practice Bulletin No.196:Thromboembolism in Pregnancy (2018)

近年来,妊娠期血栓栓塞性疾病的发病率呈上升趋势,是孕产妇死亡的主要原因之一。2018年美国妇产科医师学会(ACOG)更新了于2011年制定的《妊娠期血栓栓塞症的临床管理指南》,在妊娠期血栓栓塞性疾病的高危因素、妊娠期抗凝药物的使用、诊断、产时/产后管理等方面进行了部分更新。现根据该指南更新的循证医学证据,对该指南给出的推荐意见做一解读,以期更好地指导临床工作。

In recent years,the incidence of thromboembolism in pregnancy is increasing,which is one of the main causes of maternal mortality.In 2018,the American College of Obstetricians and Gynecologists updated its guidelines to provide information regarding the high-risk factors,use of anticoagulant drugs in pregnancy,diagnosis,intrapartum/postnatal management,and so on,and this Practice Bulletin replaces Practice Bulletin No.123(2011).The clinical recommendations from the ACOG guidelines are interpreted according to evidence-based practices,in order to better guide the clinical work.